Fellenberg Joerg, Losch Sarina, Lehner Burkhard, Arango-Ospina Marcela, Boccaccini Aldo R, Westhauser Fabian
Center for Orthopedics, Trauma Surgery and Spinal Cord Injury, Heidelberg University Hospital, Heidelberg, Germany.
Institute of Biomaterials, Department of Materials Science and Engineering, University of Erlangen-Nuremberg, Germany.
Bioact Mater. 2022 Feb 28;15:456-468. doi: 10.1016/j.bioactmat.2022.02.021. eCollection 2022 Sep.
Giant cell tumors of bone (GCTB) are associated with massive bone destructions and high recurrence rates. In a previous study, we observed cytotoxic effects of three different compositions of bioactive glasses (BGs) towards GCTSC but not bone marrow derived stromal cells (BMSC) indicating that BGs represent promising candidates for the development of new therapeutic approaches. In the current study we aimed to investigate the molecular mechanisms that are involved in BG induced cytotoxicity. We observed, that BG treatment was not associated with any signs of apoptosis, but rather led to a strong induction of mitogen activated protein kinases (MAPK) and, as a consequence, upregulation of several transcription factors specifically in GCTSC. Genome wide gene expression profiling further revealed a set of fifteen genes that were exclusively induced in GCTSC or induced significantly stronger in GCTSC compared to BMSC. BG treatment further induced autophagy that was significantly more pronounced in GCTSC compared to BMSC and could be inhibited by MAPK inhibitors. Together with the known osteogenic properties of BGs our findings support the suitability of BGs as therapeutic agents for the treatment of GCTB. However, these data have to be verified under in vivo conditions.
骨巨细胞瘤(GCTB)与大量骨质破坏和高复发率相关。在之前的一项研究中,我们观察到三种不同成分的生物活性玻璃(BGs)对GCTSC具有细胞毒性作用,但对骨髓来源的基质细胞(BMSC)没有这种作用,这表明BGs是开发新治疗方法的有前景的候选物。在当前研究中,我们旨在探究BG诱导细胞毒性所涉及的分子机制。我们观察到,BG处理与任何凋亡迹象均无关,而是导致丝裂原活化蛋白激酶(MAPK)的强烈诱导,结果是特定地在GCTSC中上调了几种转录因子。全基因组基因表达谱进一步揭示了一组15个基因,这些基因仅在GCTSC中被诱导,或者与BMSC相比在GCTSC中被诱导得明显更强。BG处理还诱导了自噬,与BMSC相比,自噬在GCTSC中明显更显著,并且可被MAPK抑制剂抑制。连同BGs已知的成骨特性,我们的发现支持BGs作为治疗GCTB的治疗剂的适用性。然而,这些数据必须在体内条件下得到验证。